A New Point Mutation (P157S) in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 Confers Low-Level Resistance to (−)-β-2′,3′-Dideoxy-3′-Thiacytidine

A P157S mutation in the reverse transcriptase (RT) of human immunodeficiency virus type 1 conferred fivefold resistance to (−)-β-2′,3′-dideoxy-3′-thiacytidine in cell culture. Interestingly, the P157S mutation resulted in increased sensitivity (two- to threefold) to 3′-azido-3′-deoxythymidine (AZT)...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Smith, Robert A., Klarmann, George J., Stray, Kirsten M., von Schwedler, Uta K., Schinazi, Raymond F., Preston, Bradley D., North, Thomas W.
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 1999
Sujets:	Antiviral Agents
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89420/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10428942/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.8.2077
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!